Healthcare Equipment and Supplies
Company Overview of CD Diagnostics, Inc.
CD Diagnostics, Inc. is an integrated diagnostics company with an expertise in immunoassay development, manufacturing, and commercialization. It develops Synovasure, a laboratory developed test for the detection of peri-prosthetic joint infection in the synovial fluid of patients experiencing pain and/or inflammation in a joint by targeting and identifying levels of alpha defensins; and point of care products. The company also provides various services, including custom companion diagnostic development programs to complement pharmaceutical drug development and other targeted therapies; biomarker screening for synovial and spinal fluids; and CLIA-certified clinical laboratory testing, includi...
650 Naamans Road
Claymont, DE 19703
Founded in 2008
Key Executives for CD Diagnostics, Inc.
Chief Executive Officer, President and Director
Co-Founder, Chief Medical Officer and Director
Vice President of Operations
Vice President of Clinical Research
Compensation as of Fiscal Year 2015.
CD Diagnostics, Inc. Key Developments
CD Diagnostics Plans Acquisitions
Feb 23 15
CD Diagnostics, Inc. plans to make acquisitions. Rick Birkmeyer, Chief Executive Officer of CD Diagnostics said: “We are also looking at several different acquisitions right now. We feel that it is important to grow and fully utilize our manufacturing capabilities so there are several companies that are in the $5 million to $15 million range of revenue that we're looking to acquire."
CD Diagnostics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
CD Diagnostics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
CD Diagnostics, Inc. Adds New Hires to Research Team in Preparation for Move to a Delaware Facility
May 16 14
CD Diagnostics, Inc. announced the addition of new hires to its research and development team. According to a release, these new hires join the CD Diagnostics' team as the company settles in to its new headquarters facility in New Castle County, Delaware. The move consolidated administrative, research and development, and manufacturing operations under one roof. These key new hires will strengthen CD Diagnostics' research and development team and position the company for future growth. CD Diagnostics reported that Martin Gould joins the company as an Immunoassay Development Fellow. Gould is a biomedical scientist with more than 40 years of experience in the diagnostic and chemical fields. He is an accomplished researcher with numerous publications in a variety of fields, including rapid immunoassay tests to detect food pathogens such as E-coli, salmonella, listeria, shigella, and campylobacter. Additionally, James W. Stave, Ph.D. joins the senior management team as Vice President of Corporate Development and Antibody Research Fellow. Prior to joining CD Diagnostics, Dr. Stave was a Senior Research Fellow at Strategic Diagnostics. He is an experienced, public biotechnology company business executive and expert immunoassay product development scientist. Jim has held positions as Chief Scientific Officer, Vice President of Research and Development, and Senior Research Fellow, and is responsible for the development of over 30 commercial test products. His fields of expertise include technology commercialization, product development, biotechnology and immunology.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|